Neuphoria Therapeutics Inc (NEUP)

03:28 AM

Neuphoria Therapeutics regains Nasdaq compliance - Investing.com

03:28 AM

Jan 09, 2025

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025

Jan 09, 2025

Bionomics Limited Publishes the Positive Results from the Phase 2 June Study of Bnc210 in Patients with Post-Traumatic Stress Disorder in Nejm Evidence - Marketscreener.com

Jan 09, 2025

Jan 09, 2025

Bionomics Limited announced that it expects to receive $70 million in funding - Marketscreener.com

Jan 09, 2025

Jan 09, 2025

Bionomics Limited to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting - Marketscreener.com

Jan 09, 2025

Jan 09, 2025

Bionomics Limited Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025

Jan 08, 2025

NEUP (Neuphoria Therapeutics) Cash From Other Investing Act - GuruFocus.com

Jan 08, 2025

Jan 06, 2025

NEUP (Neuphoria Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 06, 2025

Dec 25, 2024

We're Keeping An Eye On Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Rate - Yahoo Finance

Dec 25, 2024

Dec 24, 2024

Bionomics Strategic Shift with Neuphoria Redomiciliation - Yahoo Finance

Dec 24, 2024

Dec 24, 2024

Neuphoria Therapeutics More Than Doubles After Bionomics Re-Domiciliation - MarketWatch

Dec 24, 2024

Dec 24, 2024

Big Moves in Biotech! Neuphoria's Bold Transformation Unveiled! - Jomfruland.net

Dec 24, 2024

Dec 23, 2024

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq - GlobeNewswire

Dec 23, 2024

Dec 16, 2024

Bionomics Secures Major Court Approval for Strategic US Market Shift, Sets December Trading Timeline - StockTitan

Dec 16, 2024

Dec 13, 2024

Results of Scheme Meeting - The Manila Times

Dec 13, 2024

Nov 14, 2024

Bionomics Limited (BNOX) Quarterly 10-Q Report - Quartz

Nov 14, 2024

Nov 08, 2024

Bionomics : Scheme Implementation Agreement – Amending Agreement Form 8 K - Marketscreener.com

Nov 08, 2024

Oct 08, 2024

Bionomics CEO believes company has ‘significant, unrealized value’ - Yahoo Finance

Oct 08, 2024

Oct 07, 2024

Apeiron entities sell Bionomics shares worth $82,526 - Investing.com

Oct 07, 2024

Oct 01, 2024

Bionomics Limited announces intention to re-domicile to the United States - GlobeNewswire

Oct 01, 2024

Jul 18, 2024

Bionomics Initiates Affirm-1, A Phase 3 Clinical Trial with Bnc210 for Social Anxiety Disorder - Marketscreener.com

Jul 18, 2024

Jan 05, 2024

Bionomics to Present at Biotech Showcase™ 2024 - Marketscreener.com

Jan 05, 2024

Sep 28, 2023

Biometrics Soar After Company Says Trial of BNC210 Meets Primary Endpoint of Decrease in Severity of Post-Traumatic Stress Disorder Symptoms - Marketscreener.com

Sep 28, 2023

Jan 14, 2022

BNOXBionomics Limited American Depository Shares Latest Stock News & Market Updates - StockTitan

Jan 14, 2022